Product development resource
Oral Strip Packaging Requirements
Oral strip packaging must protect the film from its demonstrated moisture, oxygen, light and handling risks while preserving dose identity, seal integrity and an acceptable opening experience.
Short answer
Individually sealed pouches are a common working direction for oral films because they can isolate doses and protect a thin, handled product. That direction does not establish the final laminate. Material structure, barrier, sealant, dimensions, opening feature, print construction and line compatibility should be selected from product stability and process evidence.
Translate product risk into a pack brief
Start with the film's actual sensitivities. Hygroscopic behavior, moisture-driven tack or brittleness, oxidation, light sensitivity, aroma loss, migration and mechanical damage may require different controls. Ask what happens during manufacturing, transport, shelf storage and repeated consumer handling.
| Pack decision | Evidence needed |
|---|---|
| Barrier target | Stability data and product sensitivity |
| Pouch dimensions | Strip dimensions, tolerances and line handling |
| Seal construction | Seal-window and integrity evidence |
| Opening feature | Usability without damaging the strip |
| Print system | Substrate and process compatibility |
| Secondary pack | Count, organization, protection and label area |
Why laminate names are not enough
Terms such as 'tri-laminate' describe a broad construction idea, not a complete specification. Different layer materials, thicknesses, adhesives, foil or metallized layers, sealants and converting conditions can produce different barrier and sealing behavior. A supplier declaration should be connected to the exact construction offered, not a generic material family.
Packaging selection should also include machinability. A theoretically protective structure can fail if it does not feed, seal or cut reliably on the chosen line.
Validation before commercial production
Evaluate seal integrity, visual defects, opening, strip removal, product-pack compatibility and stability in the intended construction. Transport or distribution testing may be relevant to the final shipper and channel. The stability protocol and acceptance criteria should reflect product classification, target markets and intended shelf life.
Connect packaging to the manufacturing process and include its cost and line implications in the MOQ, cost and lead-time discussion.
Packaging failure modes
Watch for seal-channel leaks, edge damage, film sticking to the pouch, difficult opening, strip tearing during removal, moisture-driven tack or brittleness, aroma loss, print or adhesive compatibility problems, and pack dimensions that do not run reliably on the selected line.
Product-specific validation: a barrier specification should be justified by packaged-product stability and seal evidence. Do not publish a universal laminate or water-vapour transmission target without reviewed product data.
Evidence and sources
Evidence guide: Published evidence — supported by the linked literature. · CoManufacturing experience — practical development observations, not universal specifications. · Supplier-specific — confirm with the supplier being evaluated. · Product-specific validation — prove with the actual formula, process, pack and market.
- ICH Q1A(R2), “Stability Testing of New Drug Substances and Products,” FDA/ICH final guidance (2003)
- Ferlak, Guzenda and Osmałek, “Orodispersible Films—Current State of the Art, Limitations, Advances and Future Perspectives,” Pharmaceutics 15 (2023): 361. doi:10.3390/pharmaceutics15020361 · Full text
- Oliveira et al., “Oral disintegration films: applications and production methods,” Journal of Food Science and Technology 60 (2023): 2539–2548. doi:10.1007/s13197-022-05589-9 · Full text
ICH Q1A(R2) is pharmaceutical guidance, not a blanket rule for every oral-film category. It supports stability assessment in the proposed market pack; applicable protocols depend on classification and market.